| 1. |
葉任高, 陸在英. 主編. 內科學. 第6版. 北京: 人民衛生出版社, 2005: 572-576.
|
| 2. |
張象麟. 藥物臨床信息參考2006. 第1版. 成都: 四川科學技術出版社, 2006: 902-904.
|
| 3. |
周惠瓊, 吳東海, 馬麗. 短期小劑量甲氨蝶呤導致嚴重不良反應臨床分析. 中華風濕病學雜志, 2002, 6(2): 135-137.
|
| 4. |
Gutierrez-Urena S, Molina JF, Garcia CO, et al. Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis. Arthritis Rheum, 1996, 39(2): 272-276.
|
| 5. |
Lim AY, Gaffney K, Scott DG. Methotrexate-induced pancytopenia: serious and under-reported? Our experience of 25 cases in 5 years. Rheumatology (Oxford), 2005, 44(8): 1051-1055.
|
| 6. |
張昆鵬. 甲氨蝶呤在日本導致134例患者死亡. 世界臨床藥物, 2005, 26(4): 196.
|
| 7. |
楊毅, 張英, 王善昌. MTX致全血減少癥的臨床分析. 現代口腔醫學雜志, 1999, 13(1): 44-45.
|
| 8. |
Basile C, Montanaro A, Semeraro A. Should low-dose methotrexate therapy be prescribed to dialysis patients? Nephrol Dial Transplant, 2002, 17(3): 530-531.
|
| 9. |
Nakamura M, Sakemi T, Nagasawa K. Severe pancytopenia caused by a single administration of low-dose methotrexate in a patient undergoing hemodialysis. J Rheumatol, 1999, 26(6): 1424-1425.
|
| 10. |
Boulanger H, Launay-Vacher V, Hierniaux P, et al. Severe methotrexate intoxication in a haemodialysis patient treated for rheumatoid arthritis. Nephrol Dial Transplant, 2001, 16(5): 1087.
|
| 11. |
Bellaiche G, Maisonneuve L, Nouts A, et al. Fatal bone marrow aplasia after the 1st injection of methotrexate in a woman with Crohn’s disease. Gastroenterol Clin Biol, 1999, 23(10):1102-1103.
|
| 12. |
Rheumatoid Arthritts Clinical Trial Archive Group. The effect of age and renal function on the efficacy and toxicity of methotrexate in rheumatoid arthritis. The Journal of Rheumatol, 1995, 22(2): 2218-2231.
|
| 13. |
Seyffart G. Poison Index: The Treatment of Acute Intoxication. Pabst Science Publishers, Lengerich, 1997, 449-451.
|
| 14. |
Lacy C. Methotrexate: Drug Information in Drug Information Handbook. UpToDate Inc. 9. 1, Wellesley, 2001.
|
| 15. |
Barrie M, Grace P, John DP. Neutropenia due to low-dose methotrexate therapy for psoriasis and rheumatoid arthritis may be fatal. Med J Aust, 1991, 155(7): 480-484.
|
| 16. |
Morgan SL, Baggott J E, Vaughn WH, et al. The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis. Arthritis Rheum, 1990, 33(1): 9-18.
|
| 17. |
Fuest DE. Practical clinical pharmacology and drug interactions of low-dose methotrexate therapy in rheumatoid arthritis. Br J Rheumatol, 1995, 34(Suppl 2): 20-25.
|
| 18. |
Seyffart G. Poison Index: The Treatment of Acute Intoxication. Pabst Science Publishers, Lengerich, 1997, 449-451.
|
| 19. |
Wall SM, Johansen MJ, Molony DA, et al. Effective clearance of methatrexate using high-flux hemodialysis membranes. Am J Kidney Dis, 1996, 28(6): 846-854.
|
| 20. |
Marsh JC, Ball SE, Darbyshire P, et al. Guidelines for the diagnosis and management of acquired aplastic anaemia. Br J Haematol, 2003, 123(5): 782-801.
|
| 21. |
Hirohau M, Nobuaki K, Keiichiro T, et al. Autirheumatic agents I. novel methotrexate derivatives beating an indoline moiety. Chem. Pharm. Bull, 1996, 44(7): 1332.
|
1/5
微信公眾號